Skip to main content
Journal Article

Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer

Cancer Communications (2019) 39(1)
DOI: 10.1186/s40880-019-0417-1
22Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Folprecht, G. (2019). Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer. Cancer Communications, 39(1). https://doi.org/10.1186/s40880-019-0417-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free